Canada's main stock index declined to its lowest level in three weeks on Wednesday, with the TSX composite index closing down 260.37 points, or 0.8%, at 34,151.32. According to reports from Reuters, this marked the index's lowest closing level since May 19, reflecting broader market concerns over escalating geopolitical tensions. The latest trading session saw the S&P/TSX composite decline more than 100 points, indicating continued volatility in Canadian markets.
The market decline was primarily attributed to rising tensions between the United States and Iran, with President Trump indicating the U.S. would attack Iran 'very hard' following significant overnight exchanges of fire. As reported by Reuters, this represents one of the most significant exchanges of fire since an April ceasefire, with Trump accusing Tehran of taking too long to negotiate a deal. Brian Madden, chief investment officer at First Avenue Investment Counsel, noted that 'This sort of sabre-rattling in Iran is not helping.' Despite recent developments, Trump continues to suggest that an Iran deal is close, though market participants remain cautious about potential military escalation.
The materials group declined 4% as the price of gold fell 4.4%, with investors concerned that potential war could lead to higher interest rates globally to curb inflation. According to Reuters, major U.S. stock indexes posted steeper declines as chipmaker shares extended recent losses. However, energy stocks helped limit the TSX's decline, with the sector rising 1.6% as oil prices settled 2.1% higher at $90.03 per barrel. The Uranium sector also faced pressure, with Cameco (CCJ) dropping 7% as uranium stocks declined broadly.
The Bank of Canada maintained interest rates on hold as expected, leaving the door open to potential rate hikes if increased inflation from higher energy prices becomes more widespread. As reported by Reuters, the central bank also indicated that interest rate cuts remain possible if the U.S. imposes new tariffs on Canadian goods. Michael Constantino, CEO of Webull Canada, noted that 'By keeping both cuts and hikes in play the bank is acknowledging that policymakers are operating with genuine uncertainty.'
Despite market volatility, Apotex Health achieved significant success with its initial public offering, with shares closing 12.5% above their IPO price of C$24. According to Reuters, the IPO generated approximately C$1.3 billion in gross proceeds, making it the largest for the TSX since 2021. This milestone represents a notable bright spot in an otherwise challenging trading session for Canadian markets, with the company's shares experiencing strong debut performance in the current market environment.
